River-52: A multicenter, open-label clinical trial of RVU120 in patients with relapsed or refractory high-risk myelodysplastic syndrome or acute myeloid leukemia Meeting Abstract
| Authors: | Papayannidis, C.; Madry, K.; Centkowski, P.; Prejzner, W.; Butrym, A.; Chraniuk, D.; Saba, C.; Angelosanto, N.; Curley, R.; Nogai, H.; Dudziak, R.; Moybenko, O.; Rzymski, T.; Mazan, M.; Sroka-Porada, A.; Wilkinson, G.; Stein, E. M. |
| Abstract Title: | River-52: A multicenter, open-label clinical trial of RVU120 in patients with relapsed or refractory high-risk myelodysplastic syndrome or acute myeloid leukemia |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 6005 |
| End Page: | 6006 |
| Language: | English |
| ACCESSION: | WOS:001412527900005 |
| DOI: | 10.1182/blood-2024-206906 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
